...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1B in TNBC suspended

I just checked and it looks like NCT05422794 (treating TNBC in combination with PD1i and chemo) was suspended due to dose limiting toxicity.

This is separate from the Phase 2 that was terminated due to the futility analysis.

Hard luck in this indication. Maybe it will resume some day?

1
May 23, 2024 08:57PM
1
May 24, 2024 01:20PM
Share
New Message
Please login to post a reply